The outlook of companies tied to flagship drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key territories has introduced considerable risk . Investors are now grappling with the impact of lower-cost alt